Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Cannabis Science Inc    

CANNABIS SCIENCE INC
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCompany 
Company
Cannabis Science, Inc. develops cannabis pharmaceutical products.The company works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.Cannabis Science was founded by... 
More about the company
Latest news on CANNABIS SCIENCE INC
04/23Cannabis Science is Proud to Announce 4/20 Success! Opening of the First CBIS..
GL
04/10Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For L..
GL
04/05CANNABIS SCIENCE, INC. (OTCMKTS : CBIS) Files An 8-K Entry into a Material Defin..
AQ
04/05CANNABIS SCIENCE, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
03/30CANNABIS SCIENCE : Announces Support for the Global Hemp Group and Senator Mitch..
AQ
03/27CANNABIS SCIENCE : Announces Support for the Global Hemp Group and Senator Mitch..
AQ
03/22CANNABIS SCIENCE : Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bot..
AQ
03/19CANNABIS SCIENCE : Enters Multi-Billion USD Beverage Industry as it Partners wit..
AQ
03/19CANNABIS SCIENCE : Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bot..
AQ
03/16CROWN BAUS CAPITAL : Announces Acquisition of Cannabia
AQ
More news
Sector news : Bio Therapeutic Drugs
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Bio Therapeutic Drugs
Chart CANNABIS SCIENCE INC
Duration : Period :
Cannabis Science Inc Technical Analysis Chart | US1376481016 | 4-Traders
Managers
NameTitle
Raymond C. Dabney President, Chief Executive Officer & Director
Robert Kane Chief Operating Officer & Director
Benjamin C. K. Tam Chief Financial Officer, Secretary & Director
Richard Ogden Chief Scientific Officer
Allen A. Herman Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
CANNABIS SCIENCE INC0
GILEAD SCIENCES3.31%96 094
VERTEX PHARMACEUTICALS5.89%40 153
REGENERON PHARMACEUTICALS-15.95%33 844
GENMAB23.13%12 812
BEIGENE LTD (ADR)71.91%8 998